Catalyst Wire Dossier Catalyst Wire Dossier

BI 44370 TA oral drinking solution

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 44370 TA oral drinking solution, covering 2014-08-13 to 2014-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of BI 44370 TA Oral Drinking Solution in Healthy Male Volunteers [Phase 1]

See pricing